Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP Catheters vs Single Shot ESP Block in Pediatric Open Heart Surgery
NCT03593642Completed
- Sponsor
- Vinmec Healthcare System
- Start
- Oct 2018
- Primary completion
- Apr 2019
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms), sponsored by Vinmec Healthcare System. Primary endpoint: Morphine consumption at 48 hours. Started Oct 2018; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03593642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03593642.